Camurus AB (publ) (CAMRF)
PNK: CAMRF
· Real-Time Price · USD
59.98
0.01 (0.02%)
At close: Apr 30, 2025, 8:00 PM
0.02% (1D)
| Bid | 59.65 |
| Market Cap | 3.53B |
| Revenue (ttm) | 1.87B |
| Net Income (ttm) | 428.39M |
| EPS (ttm) | 0.74 |
| PE Ratio (ttm) | 81.05 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 67.8 |
| Volume | 100 |
| Avg. Volume (20D) | 1 |
| Open | 61.90 |
| Previous Close | 59.97 |
| Day's Range | 59.98 - 61.90 |
| 52-Week Range | 46.15 - 66.69 |
| Beta | 0.86 |
About CAMRF
Camurus AB (publ), a pharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, Japan, and internationally. The company offers Buvidal, a buprenorphine injection for the treatment of opioid dependence; episil oral liquid, a medical device for the treatment of inflammatory and painful conditions in the oral cavity; and Brixadi to treat opioid use disorder Its products pi...
Industry Biotechnology
Sector Healthcare
IPO Date Dec 11, 2017
Employees 256
Stock Exchange PNK
Ticker Symbol CAMRF
Website https://www.camurus.com